Reuters logo
BRIEF-Mithra Pharmaceuticals ‍completes recruitment for Estelle Phase III study in US and Canada​
October 30, 2017 / 6:59 AM / 2 months ago

BRIEF-Mithra Pharmaceuticals ‍completes recruitment for Estelle Phase III study in US and Canada​

Oct 30 (Reuters) - MITHRA PHARMACEUTICALS SA:

* ‍COMPLETES RECRUITMENT FOR ESTELLE® PHASE III STUDY IN US AND CANADA​

* ‍ESTELLE® PHASE III STUDY IN US/CANADA REMAINS ON TRACK TO REPORT TOP LINE DATA IN Q1 2019​

* STUDY RECRUITED 2148 WOMEN; 57% OF SUBJECTS COMPLETED OVER HALF OF 13 TREATMENT CYCLES‍​

* FIRST SUBJECT COMPLETED THE 13 CYCLE TREATMENT

* EXPECTS OUTCOME OF PHASE III TRIAL IN Q1 2019

* ‍STUDY TAKES PLACE IN AROUND 77 CENTRES ACROSS US AND CANADA, AND WILL INVOLVE SUBJECT TREATMENT FOR A PERIOD OF 12 MONTHS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below